Cargando…

A Cell-Penetrating Peptide Modified Cu(2−x)Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy

Radiotherapy (RT) is one of the main clinical therapeutic strategies against cancer. Currently, multiple radiosensitizers aimed at enhancing X-ray absorption in cancer tissues have been developed, while limitations still exist for their further applications, such as poor cellular uptake, hypoxia-ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Ran, Ruixue, Guo, Sinan, Jiang, Xiaoyu, Qian, Zhanyin, Guo, Zhaoyang, Wang, Yinsong, Cao, Mingxin, Yang, Xiaoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823383/
https://www.ncbi.nlm.nih.gov/pubmed/36615627
http://dx.doi.org/10.3390/molecules28010423
_version_ 1784866146037530624
author Ran, Ruixue
Guo, Sinan
Jiang, Xiaoyu
Qian, Zhanyin
Guo, Zhaoyang
Wang, Yinsong
Cao, Mingxin
Yang, Xiaoying
author_facet Ran, Ruixue
Guo, Sinan
Jiang, Xiaoyu
Qian, Zhanyin
Guo, Zhaoyang
Wang, Yinsong
Cao, Mingxin
Yang, Xiaoying
author_sort Ran, Ruixue
collection PubMed
description Radiotherapy (RT) is one of the main clinical therapeutic strategies against cancer. Currently, multiple radiosensitizers aimed at enhancing X-ray absorption in cancer tissues have been developed, while limitations still exist for their further applications, such as poor cellular uptake, hypoxia-induced radioresistance, and unavoidable damage to adjacent normal body tissues. In order to address these problems, a cell-penetrating TAT peptide (YGRKKRRQRRRC)-modified nanohybrid was constructed by doping high-Z element Au in hollow semiconductor Cu(2−x)Se nanoparticles for combined RT and photothermal therapy (PTT) against breast cancer. The obtained Cu(2−x)Se nanoparticles possessed excellent radiosensitizing properties based on their particular band structures, and high photothermal conversion efficiency beneficial for tumor ablation and promoting RT efficacy. Further doping high-Z element Au deposited more high-energy radiation for better radiosensitizing performance. Conjugation of TAT peptides outside the constructed Cu(2−x)Se/Au nanoparticles facilitated their cellular uptake, thus reducing overdosage-induced side effects. This prepared multifunctional nanohybrid showed powerful suppression effects towards breast cancer, both in vitro and in vivo via integrating enhanced cell penetration and uptake, and combined RT/PTT strategies.
format Online
Article
Text
id pubmed-9823383
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98233832023-01-08 A Cell-Penetrating Peptide Modified Cu(2−x)Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy Ran, Ruixue Guo, Sinan Jiang, Xiaoyu Qian, Zhanyin Guo, Zhaoyang Wang, Yinsong Cao, Mingxin Yang, Xiaoying Molecules Article Radiotherapy (RT) is one of the main clinical therapeutic strategies against cancer. Currently, multiple radiosensitizers aimed at enhancing X-ray absorption in cancer tissues have been developed, while limitations still exist for their further applications, such as poor cellular uptake, hypoxia-induced radioresistance, and unavoidable damage to adjacent normal body tissues. In order to address these problems, a cell-penetrating TAT peptide (YGRKKRRQRRRC)-modified nanohybrid was constructed by doping high-Z element Au in hollow semiconductor Cu(2−x)Se nanoparticles for combined RT and photothermal therapy (PTT) against breast cancer. The obtained Cu(2−x)Se nanoparticles possessed excellent radiosensitizing properties based on their particular band structures, and high photothermal conversion efficiency beneficial for tumor ablation and promoting RT efficacy. Further doping high-Z element Au deposited more high-energy radiation for better radiosensitizing performance. Conjugation of TAT peptides outside the constructed Cu(2−x)Se/Au nanoparticles facilitated their cellular uptake, thus reducing overdosage-induced side effects. This prepared multifunctional nanohybrid showed powerful suppression effects towards breast cancer, both in vitro and in vivo via integrating enhanced cell penetration and uptake, and combined RT/PTT strategies. MDPI 2023-01-03 /pmc/articles/PMC9823383/ /pubmed/36615627 http://dx.doi.org/10.3390/molecules28010423 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ran, Ruixue
Guo, Sinan
Jiang, Xiaoyu
Qian, Zhanyin
Guo, Zhaoyang
Wang, Yinsong
Cao, Mingxin
Yang, Xiaoying
A Cell-Penetrating Peptide Modified Cu(2−x)Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy
title A Cell-Penetrating Peptide Modified Cu(2−x)Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy
title_full A Cell-Penetrating Peptide Modified Cu(2−x)Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy
title_fullStr A Cell-Penetrating Peptide Modified Cu(2−x)Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy
title_full_unstemmed A Cell-Penetrating Peptide Modified Cu(2−x)Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy
title_short A Cell-Penetrating Peptide Modified Cu(2−x)Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy
title_sort cell-penetrating peptide modified cu(2−x)se/au nanohybrid with enhanced efficacy for combined radio-photothermal therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823383/
https://www.ncbi.nlm.nih.gov/pubmed/36615627
http://dx.doi.org/10.3390/molecules28010423
work_keys_str_mv AT ranruixue acellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy
AT guosinan acellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy
AT jiangxiaoyu acellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy
AT qianzhanyin acellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy
AT guozhaoyang acellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy
AT wangyinsong acellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy
AT caomingxin acellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy
AT yangxiaoying acellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy
AT ranruixue cellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy
AT guosinan cellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy
AT jiangxiaoyu cellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy
AT qianzhanyin cellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy
AT guozhaoyang cellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy
AT wangyinsong cellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy
AT caomingxin cellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy
AT yangxiaoying cellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy